Story perspectives
Experts Warn: Unregulated Psilocybin Market Poses Safety Risks
4/15/2026
1 of 1
Story summary
- Experts warn that growing interest in psilocybin mushrooms risks safety due to an unregulated market.
- Over 11 million adults used psilocybin in the past year, while regulation is lacking and research is limited.
- Psilocybin is a prodrug converted to psilocin and remains a Schedule I substance, hindering research.
- The market's rapid expansion echoes early cannabis legalization and could expose consumers to high-potency products without guidelines.
